EDITORIAL SECTIONS
RESEARCH & DEVELOPMENT
Adopting the Power of AI to Drug Development Projects
A tremendous amount of documentation is created throughout the clinical trial lifecycle
CLINICAL TRIALS
Real-world Evidence
Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA
MANUFACTURING
Just in Time Manufacturing Creating more sustainable supply chains
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Information Technology
Challenges and Advantages of Using Artificial Intelligence in Pharma
Many advanced largescale AI initiatives still need to be proved successful in Pharma
KNOWLEDGE BANK
Interviews
Life Sciences - Clinical, TNT Asia
Director
Clinical trials have very detailed and precise processes and the logistical elements of these processes are critical Recent revisions to the pharmaceutical industrys regulatory laws as well as improved patent laws in countries such as Japan China and India have led to the burgeoning clinical trials market in Asia
Articles
Metabolic Stability
The liability of a drug substance to the metabolism is referred to as metabolic stability The liver uses CYPmediated metabolism to clear most orally administered drugs Metabolic stability data is essential for evaluating and optimising the human therapeutic dose for the drug In vitro systems obtained fromthe human liver such as microsomes and hepatocytes
Research Insights
Ion-pairing HPLC methods to determine EDTA and DTPA in small molecule and biological pharmaceutical formulations
Abstract Ionpairing highperformance liquid chromatographyultraviolet HPLCUV methods were developed to determine two commonly used chelating agents ethylenediaminetetraacetic acid EDTA in Abilify a small molecule drug with aripiprazole as the active pharmaceutical ingredient oral solution and diethylenetriaminepentaacetic acid DTPA in Y
Case Studies
Effect Of Cold Spells And Theirmodifiers On Cardiovascular Disease Events: Evidence From A Double Prospective Study
Abstract Cardiovascular disease CVD is the most common cause of death globally remaining a considerable burden both in terms of health and costs As in many countries CVD mortality in the UK exhibits a marked seasonal variation more people die during the winter months DecemberMarch than in other periods of the year and the majority of deaths occur
Techno Trends
India's Biopharma Sector Sees Surge in R&D Investment Amid Global Collaborations
Indias biopharma sector is witnessing increased RD investments driven by global partnerships and innovative projects
White Papers
Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches
In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS
TOP ARTICLES
Nanoemulsion - A Promising Nanocarrier for Dermal Drug Delivery in Psoriasis
Sindhoor S M is currently working as an Assistant Professor in the Department of Pharmaceutics at Sri Adichunchanagiri College of Pharmacy, Mandya, Karnataka. His areas of specialisation include nanotechnology-based drug delivery system, lipid-based formulations, Topical delivery and gastroretentive in situ gel systems. He has published eight papers based on nanotechnology and lipid-based drug delivery system in peer reviewed indexed journals. Presently he is involved in the development of lipid-based delivery systems.
Marina Koland, is Professor and Head of the Department of Pharmaceutics at the NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to be University), Mangalore. Her area of specialisation in research is mucoadhesive and nanoparticulate drug delivery. She has published 50 research papers in peer reviewed journals, presented papers at 10 National and 3 International Conferences and worked on several Nitte University funded projects. She is currently working on solid lipid nanoparticles and micelles as drug carriers for targeting.
Novel Claudin Targeted C-terminal Clostridium Perfringens Enterotoxin Conjugated Anticancer Nanotherapeutics
Sushil Y. Raut Assistant Professor and Head of Research Promotion Cell, Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune. He has over 12 years of teaching and research experience. He has more than 25 research and review publications. He filed 3 Indian patents and over 20 national as well as international presentations in his credits. He is recipient of international research mobility fellowship and other prestigious awards.
Tanaji D. Nandgude, Associate Professor, Dr. D. Y. Patil institute of Pharmaceutical Sciences and Research, Pimpri, Pune. He has 15 years of experience in teaching and research in pharmacy. He has more than 50 research/review papers, more than 60 research paper presentations, 5 book publications and granted projects to his credit. He is recipient of “Young Researcher Award”.
Boosting NICU Safety
Norhan Attia, clinical pharmacist with five years' experience at Assiut University Hospital, Egypt, specialising in Neonatal Intensive Care. Expert in medication reviews, IV admixtures, and optimising pharmacotherapy outcomes. Currently a dedicated teaching assistant, focusing on pharmaceutical education and enhancing medication safety in NICU settings.
Revolutionising Tuberculosis Treatment test
Ashok Aspatwar, MS, PhD, is an Adjunct Professor at Tampere University, Finland. His research focuses on carbonic anhydrases in Mycobacterium tuberculosis persistence and anti-TB drug development, using molecular biology, medicinal chemistry, and AI-driven bioinformatics to explore novel therapeutic pathways and target mechanisms in TB.
Rarchita Sharma, M. Pharm, is a researcher at SVKM's Institute of Pharmacy, specialising in novel drug delivery for CNS disorders. She has published seven papers on topics like regulatory filings, AI in stroke care, and cardiovascular drugs, aiming to advance therapeutic innovations in pharmaceutical sciences.
press releasesRead more...
OmniAb Announces Global Collaboration and License Agreement for Ion Channel Program with Eli Lilly & Company
OmniAb Inc a provider of cuttingedge discovery research technology to enable the discovery of nextgeneration therapeutics today announced a global collaboration and license agreement with Eli Lilly and Company Lilly for a new ion channel program The collaboration leverages
WuXi XDC Achieves GMP Release of BCM3 Facility at Singapore Site, Enabling Global Clients with Professional Excellence
WuXi XDC Cayman Inc WuXi XDC stock code HK a leading global Contract Research Development and Manufacturing Organization CRDMO focused on the bioconjugate industry
SK bioscience Advances Development of Next-Generation Infectious Disease Prevention Platform with Global Phase 1b CTA Submission for RSV Preventive Antibody Candidate
SK bioscience announced that it has submitted a Clinical Trial Application CTA to the South African Health Products Regulatory Authority SAHPRA for a global pediatric Phase b clinical trial of RSM
Cognizant and Benchling Selected as Partners to Accelerate Kyowa Kirin's R&D
Cognizant NASDAQ CTSH today announced that it will support the introduction and implementation of Benchling the AI platform for RD at Tokyo Research Park and Fuji Research Park
Lonza Launches Rapid Custom Media Prototyping Service to Accelerate Early Bioprocess Development
Lonza the worlds leading contract development and manufacturing organization CDMO today announced its Rapid Media Prototyping Service RaMP giving biopharmaceutical companies faster access
Xanadu and University of Alberta Partner to Accelerate Pharmaceutical Discoveries with Quantum Computing
Xanadu Quantum Technologies Limited Xanadu NASDAQTSX XNDU a leading photonic quantum computing company and the University of Alberta have announced a strategic research partnership
EventsRead more...
19 - 21
Aug 2026ISPE Singapore Conference & Exhibition 2026
Suntec Singapore
20 - 21
Aug 2026Pharmaceutical Formulations 2026
London, UK
20 - 21
Aug 2026Novel Drug Delivery Systems 2026
London, UK
20 - 21
Aug 2026Advanced Clinical Research 2026
London, UK
25 - 27
Aug 2026CPHI Korea 2026
COEX, Seoul, Korea
26 - 27
Aug 2026BIOMEDevice 2026
Boston Convention & Exhibition...
03 - 05
Sep 20265th MENA Congress for Rare Diseases 2026
Beach Rotana Hotel, Abu Dhabi,...
14 - 15
Sep 202616th American DDF Summit
Omni Boston Hotel at the Seapo...
LATEST NEWSRead more...
TCS launches Agentic AI platform to transform drug development
Tata Consultancy Services TCS a global IT services consulting and business solutions company has launched TCS ADD AgentHub an enterpriseready AI platform designed to support the use of agentic AI across drug development
Tagomics introduces LiquiPath, a cfDNA-based blood test for multi-organ drug safety monitoring
Tagomics Ltd a precision medicine company has launched LiquiPath a crossspecies multiorgan liquid pathology platform designed for noninvasive drug safety monitoring The platform is intended for use
Sandoz announces strategic collaboration with Henlius on up to 10 biosimilars, expanding its pipeline
Sandoz has entered into a development manufacturing and commercialisation agreement with Shanghai Henlius Biotech to collaborate on up to biosimilar medicines The partnership aims to expand access to affordable biosimilar treatments worldwide
Bristol Myers Squibb’s ZENBEXUS Receives FDA Accelerated Approval for Multiple Myeloma
Bristol Myers Squibb has announced that the US Food and Drug Administration FDA has granted accelerated approval to ZENBEXUS iberdomide in combination with daratumumab and hyaluronidasefihj and dexamethasone
Aurisco Pharmaceutical Becomes First Generic Oligonucleotide Manufacturer to Successfully Complete US FDA Inspection
Aurisco Pharmaceutical has announced that its manufacturing site in Yangzhou China has successfully completed a US Food and Drug Administration FDA inspection making it the first generic oligonucleotide active pharmaceutical ingredient API manufacturer to pass a US FDA inspection according to the co...
Bruker and Atinary Technologies Expand Collaboration on AI-Driven Self-Driving Laboratories
Bruker Corporation has expanded its strategic collaboration with Atinary Technologies to advance selfdriving laboratory technologies and AIdriven research and development Bruker has also made a minority investment in Atinary although financial details were not disclosed